Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Conditions › Aspergillosis

Aspergillosis

Part of Fungal infection

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials for Aspergillosis

10 trials tracked for Aspergillosis: 7 in phase 3 or 4.

10Trials tracked
7Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 4 1 Phase 3 6 Phase 2 1 Other / NA 2
  1. Phase 4 A Study To Assess The Anidulafungin And Voriconazole Concentration In Lung Following Intravenous Administration In Healthy Subjects Completed
  2. Phase 3 Assessing the Safety and Efficacy of MK-5592 (Posaconazole) in Japanese Participants With Fungal Infection (MK-5592-101) Completed
  3. Phase 3 Voriconazole For Chronic Bronchopulmonary Aspergillosis Completed
  4. Phase 3 Isavuconazole in the Treatment of Renally Impaired Aspergillosis and Rare Fungi Completed
  5. Phase 3 A Pharmacokinetic Study of JK1211(Itraconazole [Itrizole]) Oral Solution in Participants With Deep Mycosis and Those With Febrile Neutropenia Suspected of Fungal Infection Completed
  6. Phase 3 Isavuconazole (BAL8557) for Primary Treatment of Invasive Aspergillosis Completed
Show 4 more trials
  1. Phase 3 Anidulafungin Plus Voriconazole Versus Voriconazole For The Treatment Of Invasive Aspergillosis Completed
  2. Phase 2 A Study of Caspofungin (MK-0991) in Japanese Children and Adolescents With Documented Candida or Aspergillus Infections (MK-0991-074) Completed
  3. N/A An Observational Study of Fungal Biomarkers (MK-0000-089) Completed
  4. N/A Posaconazole Prophylaxis for CAPA Prevention in Critically-Ill Patients Completed

Showing the 10 most-cited and recently-updated of 10 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Laboratory study evaluates antifungal susceptibility of Aspergillus from Costa Rican coffee beans
Primary Care & Family Medicine Guideline
Laboratory study evaluates antifungal susceptibility of Aspergillus from Costa Rican coffee beans Lab study finds coffee bean fungi often resist common antifungal drugs
This laboratory study evaluated antifungal susceptibility of Aspergillus spp. isolated from coffee beans in Costa Rica. The authors report m…
Laboratory testing of fungi from Costa Rican coffee beans shows many strains resist standard antifungal medications like amphotericin B and …
Frontiers May 20, 2026